Dr. Jason Margolesky, MD

Dr. Margolesky practices at UMiami Medicine - Neurology in Miami, Florida.

Dr. Margolesky's NPI, 1801162813, was assigned on March 24, 2012. Dr. Margolesky graduated from University of Miami Leonard M. Miller School of Medicine in 2012. Dr. Margolesky holds Florida license ME127589.

Dr. Margolesky's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Dr. Margolesky's primary practice is UMiami Medicine - Neurology in Miami, Florida. Dr. Margolesky is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Margolesky to 1 more hospital and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Margolesky practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Margolesky's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Margolesky is licensed in Florida.

CMS data shows 5,284 Medicare services from Dr. Margolesky across 9 procedure codes in 2024, for 187 Medicare patients. Medicare paid $54,334 for them.

CMS counts 187 Medicare patients who saw Dr. Margolesky in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 33% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Margolesky's median patient age at 72, with 59% women.

In 2024, Dr. Margolesky wrote 1,998 Medicare Part D claims for 280 patients. 75% of them were for generic drugs. CMS names the drug for 1,806 of them, across 40 drugs with 11 or more claims each, at $875,599 in total drug cost. In 2023, CMS named 1,655 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Margolesky for performance year 2024, reported as part of a group. Dr. Margolesky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Margolesky as offering telehealth.

Dmand AI links 51 papers to Dr. Margolesky, published from 2015 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Parkinson Disease, Antiparkinson Agents and Levodopa. Dr. Margolesky has published most often in Neurology. Dr. Margolesky's most frequent co-authors are Carlos Singer, Danielle Spengler Shpiner, MD and Henry Paul Moore, MD.

CMS Open Payments shows 67 general payments to Dr. Margolesky from 18 drug and device companies from 2016 to 2025. Grants make up the largest share, 87% of the total. Medtronic USA, Inc. paid the most, $25,019. It also lists 2 research payments totaling $12,171 from 2023 to 2025.

Dr. Margolesky graduated from University of Miami Leonard M. Miller School of Medicine in 2012.